Filing Flows › Nutex Health (NUTX) › Capital expenditures
Nutex Health (NUTX) capital expenditures by quarter
Nutex Health's capital expenditures were $5.2M in Q3 2026 (third quarter 2026), +105% from Q2 2026. Over the last 7 quarters it ranged from $64K (Q1 2025) to $5.2M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.2M | +105% | 17× |
| Q2 2026 | $2.5M | +111% | +238% |
| Q1 2026 | $1.2M | -15% | 19× |
| Q4 2025 | $1.4M | +367% | — |
| Q3 2025 | $302K | -60% | — |
| Q2 2025 | $751K | 12× | — |
| Q1 2025 | $64K | — | — |
Q3 2026 at a glance
Nutex Health, Q3 2026: revenue $218M (-19% year over year), operating margin 35.4%, net earnings $40.2M, operating cash flow $78.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Nutex Health's capital expenditures?
Nutex Health's capital expenditures were $5.2M in Q3 2026 (third quarter 2026), +105% from Q2 2026.
How has Nutex Health's capital expenditures changed?
Over the last 7 quarters it ranged from $64K (Q1 2025) to $5.2M (Q3 2026).